New global research shows that chronic kidney disease is climbing the ranks of leading causes of death, while millions of ...
Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...
ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...
Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...
(HealthDay News) — Chronic kidney disease (CKD) reduces quality of life (QoL) for patients and their caregivers globally, according to a study published online Dec. 24 in Advances in Therapy.
In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...
This review synthesizes clinical, genetic, and mechanistic evidence showing that suPAR and related uPAR fragments are ...
Nearly 1 in 7 adults in the United States lives with chronic kidney disease, a condition that often advances quietly until ...
The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...
Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...
LIMESTONE COUNTY, Ala. (WHNT) — A Limestone County family received a call they had been waiting months for on Monday. Ruger ...